The clinical trial of a new hypotensive agent, "fusaric acid (5-butylpicolinic acid)": the preliminary report.
D000368:Aged; D000469:Alkaline Phosphatase / Q000097:blood; D000959:Antihypertensive Agents / Q000494:pharmacology / Q000627:therapeutic use*; D001772:Blood Cell Count; D001794:Blood Pressure / Q000187:drug effects; D001798:Blood Proteins / Q000032:analysis; D001806:Blood Urea Nitrogen; D002784:Cholesterol / Q000097:blood; D002986:Clinical Trials as Topic; D004562:Electrocardiography; D005260:Female; D006454:Hemoglobins / Q000032:analysis; D006801:Humans; D007770:L-Lactate Dehydrogenase / Q000097:blood; D008297:Male; D006899:Mixed Function Oxygenases / Q000037:antagonists & inhibitors; D010848:Picolinic Acids / Q000494:pharmacology / Q000627:therapeutic use*; D011507:Proteinuria; D000637:Transaminases / Q000097:blood
D000959:Antihypertensive Agents; D001798:Blood Proteins; D006454:Hemoglobins; D010848:Picolinic Acids; D002784:Cholesterol; D006899:Mixed Function Oxygenases; D007770:L-Lactate Dehydrogenase; D000637:Transaminases; D000469:Alkaline Phosphatase